WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexeo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tai Sandi SeeChief Development Officer2025-10-173,844$8.94
$34.35kSell
Eric AdlerChief Medical Officer2025-10-173,344$8.94
$29.88kSell
Eric AdlerChief Medical Officer2025-10-1738$9.56
$363.32Sell
Richard Nolan TownsendChief Executive Officer2025-10-17148$9.56
$1.42kSell
Jose Manuel OteroChief Technical Officer2025-10-172,091$8.94
$18.68kSell
Jose Manuel OteroChief Technical Officer2025-10-1724$9.56
$229.46Sell
Richard Nolan TownsendChief Executive Officer2025-10-1712,985$8.94
$116.02kSell
Jenny RobertsonChief Legal Officer2025-10-173,486$8.94
$31.15kSell
Jenny RobertsonChief Legal Officer2025-10-1740$9.56
$382.44Sell
Tai Sandi SeeChief Development Officer2025-10-1744$9.56
$420.68Sell

1 of 4

LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXEO insiders and whales buy or sell their stock.

LXEO Shareholders

What type of owners hold Lexeo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP8.19%4,424,725$41.73MInstitution
Balyasny Asset Management LP7.42%4,009,137$37.81MInstitution
Janus Henderson Group PLC6.82%3,684,383$34.74MInstitution
Citadel Advisors LLC6.68%3,607,967$34.02MInstitution
Affinity Asset Advisors LLC6.65%3,589,355$33.85MInstitution
Vestal Point Capital LP5.98%3,228,161$30.44MInstitution
Millennium Management LLC5.25%2,836,292$26.75MInstitution
Woodline Partners LP4.76%2,572,162$24.26MInstitution
Longitude Capital Partners IV LLC4.75%2,567,100$24.21MInsider
Omega Fund VI LP4.00%2,157,623$20.35MInsider

1 of 3

LXEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXEO78.28%13.35%Net SellingNet Selling
FDMT76.10%23.90%Net SellingNet Selling
MNPR14.23%85.77%Net SellingNet Selling
KALV57.28%42.72%Net BuyingNet Selling
GOSS77.95%15.17%Net BuyingNet Buying
View Top Biotech Stocks

Lexeo Therapeutics Stock Ownership FAQ

Who owns Lexeo Therapeutics?

Lexeo Therapeutics (NASDAQ: LXEO) is owned by 78.28% institutional shareholders, 13.35% Lexeo Therapeutics insiders, and 8.37% retail investors. Longitude Capital Partners IV LLC is the largest individual Lexeo Therapeutics shareholder, owning 2.57M shares representing 4.75% of the company. Longitude Capital Partners IV LLC's Lexeo Therapeutics shares are currently valued at $25.70M.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.